Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
300957 Yunnan Botanee Bio-Technology Group
- 51.05
- +1.02+2.04%
Market Closed Dec 12 15:00 CST
21.62BMarket Cap36.52P/E (TTM)
51.18High49.60Low81.23KlotVolume49.88Open50.03Pre Close411.73MTurnover1.92%Turnover Ratio28.57P/E (Static)423.60MShares74.0052wk High3.66P/B21.62BFloat Cap39.3052wk Low60.04Limit Up423.60MShs Float287.35Historical High40.02Limit Down3.16%Amplitude39.30Historical Low0.60Dividend TTM50.69Avg Price35.21KlotAsk1.18%Div YieldTTM100Lot Size41.49KlotBid
Yunnan Botanee Bio-Technology Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 17.09%4.02B | 18.45%2.8B | 27.06%1.1B | 10.14%5.52B | 18.51%3.43B | 15.52%2.37B | 6.78%863.31M | 24.65%5.01B | 37.05%2.9B | 45.19%2.05B |
| Operating revenue | 17.09%4.02B | 18.45%2.8B | 27.06%1.1B | 10.14%5.52B | 18.51%3.43B | 15.52%2.37B | 6.78%863.31M | 24.65%5.01B | 37.05%2.9B | 45.19%2.05B |
| Other operating revenue | ---- | 35.02%13.31M | ---- | 27.49%20.55M | ---- | 5.52%9.85M | ---- | 10.14%16.12M | ---- | 1.86%9.34M |
| Total operating cost | 27.09%3.63B | 20.27%2.35B | 29.55%931.18M | 22.30%4.81B | 21.25%2.86B | 19.75%1.95B | 8.34%718.76M | 29.01%3.93B | 38.99%2.36B | 48.47%1.63B |
| Operating cost | 30.44%1.06B | 31.86%768.69M | 48.44%306.2M | 15.96%1.44B | 20.39%809.23M | 23.11%582.95M | 15.01%206.28M | 28.79%1.24B | 37.75%672.18M | 47.04%473.53M |
| Operating tax surcharges | -12.27%30.9M | -15.42%20.28M | 10.44%8.6M | 16.19%65.18M | 17.04%35.22M | 9.30%23.97M | 9.56%7.79M | 7.64%56.1M | 12.16%30.09M | 13.40%21.93M |
| Operating expense | 25.27%2.01B | 16.41%1.28B | 24.75%512.65M | 27.43%2.61B | 19.96%1.6B | 17.80%1.1B | 5.85%410.94M | 21.84%2.05B | 36.80%1.34B | 46.15%931.42M |
| Administration expense | 39.04%339.56M | 15.01%175.21M | 13.54%75.65M | 20.45%413.2M | 20.52%244.21M | 16.31%152.34M | 8.68%66.63M | 39.73%343.04M | 41.01%202.63M | 55.91%130.98M |
| Financial expense | 83.62%-2.69M | 52.51%-5.26M | 33.09%-4.57M | -48.35%-21.3M | -47.31%-16.44M | -48.77%-11.08M | -90.03%-6.84M | -42.64%-14.36M | -33.76%-11.16M | 0.38%-7.45M |
| -Interest expense (Financial expense) | 217.66%12.02M | 179.53%6.79M | 152.10%2.77M | 4.50%4.97M | 1.35%3.78M | 2.75%2.43M | --1.1M | 13.51%4.75M | --3.73M | --2.36M |
| -Interest Income (Financial expense) | 22.66%-16.28M | 8.13%-13.08M | 8.21%-7.59M | -40.63%-28.55M | -32.25%-21.05M | -34.26%-14.23M | -67.26%-8.27M | -37.22%-20.3M | -35.58%-15.92M | -13.77%-10.6M |
| Research and development | 9.78%199.75M | 4.97%114.29M | -3.85%32.65M | 17.32%298.82M | 43.88%181.95M | 33.58%108.88M | 9.54%33.96M | 124.96%254.7M | 84.66%126.45M | 85.47%81.51M |
| Credit Impairment Loss | 10.90%-16.78M | 32.34%-7.21M | 72.52%-752.58K | -2,079.17%-14.26M | -229.31%-18.83M | -699.26%-10.65M | -192.31%-2.74M | 113.68%720.65K | -103.12%-5.72M | 352.44%1.78M |
| Asset Impairment Loss | 3.29%-10.03M | -83.87%-7.17M | 135.29%1.52M | -6.38%-20.2M | -4.18%-10.37M | -512.93%-3.9M | -241.66%-4.31M | -59.36%-18.99M | 50.03%-9.96M | 106.87%944.69K |
| Other net revenue | 39.84%89.05M | 4.83%87.99M | -1.96%34.93M | 26.53%162.77M | 3.00%63.68M | 70.86%83.94M | 16.82%35.63M | 221.52%128.64M | 1,205.10%61.83M | 893.92%49.13M |
| Fair value change income | 172.28%17.37M | 67.71%20.71M | -60.43%12.44M | -212.31%-17.24M | -746.90%-24.03M | 463.88%12.35M | 1,581.50%31.45M | -151.12%-5.52M | --3.71M | -267.86%-3.39M |
| Invest income | 4.80%46.07M | 29.18%34.73M | 85.91%10.58M | -20.12%64.36M | -18.71%43.95M | -39.36%26.88M | -73.62%5.69M | 327.92%80.58M | 575.62%54.07M | 1,111.06%44.33M |
| -Including: Investment income associates | 135.58%6.07M | 210.49%6.24M | ---145.04K | 277.65%9.71M | 260.39%2.58M | 597.45%2.01M | ---- | --2.57M | --714.7K | ---403.91K |
| Asset deal income | -263.34%-1.13M | -312.09%-1.39M | 339.51%3.16M | 2,593.30%690.28K | 2,592.32%690.01K | --656.81K | --718.88K | -105.36%-27.69K | -77.07%-27.69K | ---- |
| Other revenue | -25.89%53.56M | -17.53%48.33M | 65.47%7.99M | 107.88%149.42M | 265.94%72.27M | 971.81%58.6M | 355.43%4.83M | 165.76%71.88M | 1.32%19.75M | -56.74%5.47M |
| Operating profit | -25.56%473.77M | 9.02%542.28M | 11.39%200.7M | -27.57%877.97M | 6.16%636.42M | 6.54%497.43M | 2.61%180.18M | 19.34%1.21B | 42.38%599.48M | 47.06%466.89M |
| Add:Non operating Income | 212.55%1.87M | 34.63%654.24K | -32.98%268.59K | -76.10%2.14M | -91.92%597.38K | -93.02%485.97K | -93.61%400.77K | -17.74%8.95M | -1.29%7.4M | 2,021.89%6.97M |
| Less:Non operating expense | 51.91%12.39M | 25.81%8.59M | -8.95%6.02M | 56.97%11.29M | 16.46%8.15M | -1.87%6.83M | 24.19%6.61M | -17.44%7.19M | -18.72%7M | 63.51%6.96M |
| Total profit | -26.33%463.26M | 8.81%534.34M | 12.06%194.94M | -28.43%868.82M | 4.83%628.87M | 5.18%491.08M | -1.46%173.97M | 19.25%1.21B | 42.85%599.88M | 48.90%466.9M |
| Less:Income tax cost | -7.91%58.74M | 16.36%58.76M | 18.75%22.51M | -32.89%109.61M | -24.40%63.78M | -30.66%50.5M | -39.13%18.95M | 6.19%163.33M | 31.49%84.37M | 50.25%72.83M |
| Net profit | -28.41%404.52M | 7.94%475.58M | 11.24%172.44M | -27.73%759.21M | 9.62%565.08M | 11.80%440.58M | 6.60%155.02M | 21.58%1.05B | 44.90%515.51M | 48.66%394.07M |
| Net profit from continuing operation | -28.41%404.52M | 7.94%475.58M | 11.24%172.44M | -27.73%759.21M | 9.62%565.08M | 11.80%440.58M | 6.60%155.02M | 21.58%1.05B | 44.90%515.51M | 48.66%394.07M |
| Less:Minority Profit | 27.33%-10.25M | 13.13%-8.19M | -35.65%-4.41M | 402.16%2.42M | -684.72%-14.11M | -869.73%-9.43M | -473.41%-3.25M | -170.19%-799.81K | -456.01%-1.8M | -1,491.78%-972.27K |
| Net profit of parent company owners | -28.39%414.77M | 7.50%483.77M | 11.74%176.85M | -28.02%756.8M | 11.96%579.19M | 13.91%450.01M | 8.41%158.27M | 21.83%1.05B | 45.62%517.31M | 49.06%395.04M |
| Earning per share | ||||||||||
| Basic earning per share | -27.74%0.99 | 8.49%1.15 | 13.51%0.42 | -27.82%1.79 | 12.30%1.37 | 13.98%1.06 | 8.82%0.37 | 16.98%2.48 | 38.64%1.22 | 36.76%0.93 |
| Diluted earning per share | -27.94%0.98 | 8.49%1.15 | 13.51%0.42 | -27.82%1.79 | 11.48%1.36 | 13.98%1.06 | 8.82%0.37 | 16.98%2.48 | 38.64%1.22 | 36.76%0.93 |
| Other composite income | 1.71M | -1.73M | -1.15M | -37,919.67%-78.93K | -10,585.35%-207.61 | -1.9K | -707.51 | |||
| Other composite income of parent company owners | --1.71M | ---1.73M | ---1.2M | 22,911.58%47.36K | ---- | ---- | ---- | -10,585.35%-207.61 | ---1.9K | ---707.51 |
| Other composite income of minority owners | ---- | ---- | --46.96K | ---126.29K | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | -28.11%406.22M | 7.55%473.84M | 10.50%171.29M | -27.74%759.13M | 9.62%565.08M | 11.80%440.58M | 6.60%155.02M | 21.58%1.05B | 44.90%515.51M | 48.66%394.07M |
| Total composite income of parent company owners | -28.09%416.48M | 7.12%482.03M | 10.98%175.65M | -28.01%756.84M | 11.96%579.19M | 13.91%450.01M | 8.41%158.27M | 21.83%1.05B | 45.62%517.3M | 49.06%395.04M |
| Total composite income of minority owners | 27.33%-10.25M | 13.13%-8.19M | -34.20%-4.36M | 386.37%2.29M | -684.72%-14.11M | -869.73%-9.43M | -473.41%-3.25M | -170.19%-799.81K | -456.01%-1.8M | -1,491.78%-972.27K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
